2
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T78989 | BET-IN-16 | Epigenetic Reader Domain | |
BET-IN-16 (Comp I), a bromodomain and extra-terminal (BET) inhibitor, demonstrates anticancer activity by impeding the growth of prostate cancer cells. It exhibits potent inhibitory effects with half-maximal inhibitory c... | |||
T79610 | BET-IN-17 | Epigenetic Reader Domain | |
BET-IN-17, also known as compound 16, serves as a pan-inhibitor for BET, exhibiting inhibitory potencies (pIC50) of 7.8 for BET BD1 and 7.6 for BET BD2 [1]. |